Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Clinical Trial to Assess the Efficacy and Safety of EPOGAM 1000 in Patients With Atopic Dermatitis (Explorative Pilot Study)

NCT00878670 is registered in ClinicalTrials.gov with Max Zeller Soehne AG as lead sponsor.

NCT NCT00878670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00878670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Clinical Trial to Assess the Efficacy and Safety of EPOGAM 1000 in Patients With Atopic Dermatitis (Explorative Pilot Study)
Lead sponsor
Max Zeller Soehne AG
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2009
Completion date
October 31, 2010
Enrollment
23 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis, neurodermatitis